Home » Topics » Ear, nose and throat, BioWorld Science

Ear, nose and throat, BioWorld Science
RSS

Auris Medical reports results from extension study of AM-101 for tinnitus

May 10, 2017

Auris Medical reports results from Keyzilen extension study AMPACT2 in acute inner ear tinnitus

April 25, 2017

AAV8-whirlin restores balance and auditory function in preclinical model of Usher syndrome

April 19, 2017

Spiral signs option agreement with Bionure for SGK agonists for inner ear disorders

March 31, 2017

FDA grants fast track designation to Auris Medical's AM-111

Feb. 27, 2017

Auris Medical extends collaboration with King's College London

Feb. 23, 2017

European Commission awards orphan drug designation to SENS-401

Nov. 28, 2016

Sensorion reports results from phase I study of SENS-218 for inner ear lesions

Sep. 8, 2016

Auris Medical's phase III trial of Keylizen does not meet its two coprimary efficacy endpoints

Aug. 19, 2016

FDA's clinical hold on CGF-166 lifted

July 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...